Genetic epidemiology of type 1 diabetes
暂无分享,去创建一个
[1] Nunzio Bottini,et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant , 2005, Nature Genetics.
[2] Steven J. Schrodi,et al. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. , 2005, American journal of human genetics.
[3] Grant Morahan,et al. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. , 2005, Diabetes.
[4] J. Ilonen,et al. Lack of association of PAX4 gene with type 1 diabetes in the Finnish and Hungarian populations. , 2005, Diabetes.
[5] C. Wollheim,et al. Reply to comment on: Biason-Lauber A, Boehm B, Lang-Muritano M et al. (2005) Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900–905 , 2005, Diabetologia.
[6] A. Paterson. To: Biason-Lauber A, Boehm B, Lang-Muritano M et al. (2005) Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900–905 , 2005, Diabetologia.
[7] J. Todd,et al. Comment to: Biason-Lauber A, Boehm B, Lang-Muritano M et al. (2005) Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900–905 , 2005, Diabetologia.
[8] F. Pociot,et al. To: Biason-Lauber A, Boehm B, Lang-Muritano M et al. (2005) Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900–905 , 2005, Diabetologia.
[9] E. G. de la Concha,et al. Th1 cytokine polymorphisms in spanish patients with type 1 diabetes. , 2005, Human immunology.
[10] Elizabeth L. Ogburn,et al. Demonstrating stratification in a European American population , 2005, Nature Genetics.
[11] C Polychronakos,et al. Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype? , 2005, Journal of Medical Genetics.
[12] Jacqueline K. Wittke-Thompson,et al. Rational inferences about departures from Hardy-Weinberg equilibrium. , 2005, American journal of human genetics.
[13] E. Eichler,et al. Fine-scale structural variation of the human genome , 2005, Nature Genetics.
[14] F. Pociot,et al. OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes. , 2005, Diabetes.
[15] Adrian Vella,et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. , 2005, American journal of human genetics.
[16] P. Concannon,et al. Functional variants in SUMO4, TAB2, and NFκB and the risk of type 1 diabetes , 2005, Genes and Immunity.
[17] C. Wollheim,et al. Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity , 2005, Diabetologia.
[18] F. Pociot,et al. Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. , 2005, American journal of human genetics.
[19] G. Eisenbarth,et al. The stages of type 1A diabetes: 2005 , 2005, Immunological reviews.
[20] T. Hudson,et al. Confirmation of the association of the R620W polymorphism in the protein tyrosine phosphatase PTPN22 with type 1 diabetes in a family based study , 2005, Journal of Medical Genetics.
[21] J. She,et al. Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes. , 2005, Diabetes.
[22] Geoffrey B. Nilsen,et al. Whole-Genome Patterns of Common DNA Variation in Three Human Populations , 2005, Science.
[23] D. Strachan,et al. Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetes , 2005, BMC Genetics.
[24] D. Strachan,et al. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes , 2005, Nature Genetics.
[25] Xiao-qing Liu,et al. To the editor [3] , 2005 .
[26] J. Tuomilehto,et al. Cumulative incidence of type 1 diabetes in 10,168 siblings of Finnish young-onset type 1 diabetic patients. , 2005, Diabetes.
[27] J. She,et al. In reply [5] , 2005 .
[28] H. Stefánsson,et al. A common inversion under selection in Europeans , 2005, Nature Genetics.
[29] Yang Wang,et al. T1DBase, a community web-based resource for type 1 diabetes research , 2004, Nucleic Acids Res..
[30] R. Spielman,et al. A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families , 2004, Genes and Immunity.
[31] I. James,et al. Alleles of the IL12B 3'UTR associate with late onset of type 1 diabetes. , 2004, Human immunology.
[32] Adrian Vella,et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. , 2004, Diabetes.
[33] C. Larsen,et al. The genetics of HLA-associated disease. , 2004, Current opinion in immunology.
[34] L. Feuk,et al. Detection of large-scale variation in the human genome , 2004, Nature Genetics.
[35] Kristin G Ardlie,et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. , 2004, American journal of human genetics.
[36] J. She,et al. A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes , 2004, Nature Genetics.
[37] Steven J. Schrodi,et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. , 2004, American journal of human genetics.
[38] G. A. Fleming,et al. Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264)) , 2004 .
[39] Anthony J Brookes,et al. Complex SNP-related sequence variation in segmental genome duplications , 2004, Nature Genetics.
[40] K. Bohren,et al. A M55V Polymorphism in a Novel SUMO Gene (SUMO-4) Differentially Activates Heat Shock Transcription Factors and Is Associated with Susceptibility to Type I Diabetes Mellitus* , 2004, Journal of Biological Chemistry.
[41] F. Pociot,et al. Genetic and functional evaluation of an interleukin-12 polymorphism (IDDM18) in families with type 1 diabetes , 2004, Journal of Medical Genetics.
[42] Nunzio Bottini,et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes , 2004, Nature Genetics.
[43] Toshihiro Tanaka. The International HapMap Project , 2003, Nature.
[44] J. Kaprio,et al. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. , 2003, Diabetes.
[45] M. Olivier. A haplotype map of the human genome , 2003, Nature.
[46] Jh Edwards. Sib‐pairs in multifactorial disorders: the sib‐similarity problem , 2003, Clinical genetics.
[47] D. Middleton,et al. The IL12B 3′ untranslated region DNA polymorphism is not associated with early-onset type 1 diabetes , 2002, Genes and Immunity.
[48] J. Tuomilehto,et al. Preferential transmission of type 1 diabetes from parents to offspring: fact or artifact? , 2002, Genetic epidemiology.
[49] Jeremy Heil,et al. Human diallelic insertion/deletion polymorphisms. , 2002, American journal of human genetics.
[50] J. She,et al. IL-12p40 is associated with type 1 diabetes in Caucasian-American families. , 2002, Diabetes.
[51] L. Nisticò,et al. IL12B polymorphism and type 1 diabetes in the Italian population: a case-control study. , 2002, Diabetes.
[52] Veronica J. Vieland,et al. HLODs, Trait Models, and Ascertainment: Implications of Admixture for Parameter Estimation and Linkage Detection , 2002, Human Heredity.
[53] John A. Todd,et al. Parameters for reliable results in genetic association studies in common disease , 2002, Nature Genetics.
[54] T. Waldhör,et al. Incidence of Type I diabetes mellitus in children and young adults in the province of Upper Austria, 1994 –1996 , 2001, Diabetologia.
[55] E. Thorsby,et al. The polymorphism in the 3′ untranslated region of IL12B has a negligible effect on the susceptibility to develop type 1 diabetes in Norway , 2001, Immunogenetics.
[56] G. Morahan,et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele , 2001, Nature Genetics.
[57] J. Ott,et al. Sometimes it's hot, sometimes it's not , 1998, Nature Genetics.
[58] D. Pyke,et al. Evidence That the Age at Diagnosis of IDDM Is Genetically Determined , 1998, Diabetes Care.
[59] Å. Lernmark,et al. Family cell lines available for research--an endangered resource? , 1997, American journal of human genetics.
[60] A. Green,et al. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins , 1995, BMJ.
[61] F. Pociot,et al. A nationwide population-based study of the familial aggregation of Type 1 (insulin-dependent) diabetes mellitus in Denmark , 1993, Diabetologia.
[62] J. Weber,et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. , 1992, Science.
[63] M. King,et al. Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.
[64] J. Ilonen,et al. A comparison of childhood and adult type I diabetes mellitus. , 1989, The New England journal of medicine.
[65] C. Liddle,et al. The histopathology of the pancreas in Type I (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom , 1986, Diabetologia.
[66] P. Concannon,et al. The genetics of type 1 diabetes: lessons learned and future challenges. , 2005, Journal of autoimmunity.
[67] Deborah A Nickerson,et al. Comprehensive identification and characterization of diallelic insertion-deletion polymorphisms in 330 human candidate genes. , 2005, Human molecular genetics.
[68] N. Bottini,et al. Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. , 2005, Human immunology.
[69] G. A. Fleming,et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. , 2004, Diabetes.
[70] J. Pritchard,et al. Evidence for extensive transmission distortion in the human genome. , 2004, American journal of human genetics.
[71] P. Bingley,et al. High familial risk and genetic susceptibility in early onset childhood diabetes. , 2002, Diabetes.
[72] Richard A. King,et al. The genetic basis of common diseases. , 2002 .
[73] C. Patterson,et al. Familial Risk of Type I diabetes in European Children , 1999 .